These findings confirm that the activation of pre-synaptic receptor accounts for the effect of combined low doses of 5-HT1A and 5-HT1B agonists on mild dyskinesias, whereas other mechanisms may explain the more severe apomorphine-induced AIMs. This evidence concerns the gene HTR1A and drug-induced dyskinesia.